Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
The St. Jude Children’s Research Hospital-led national BABY HUG trial linked hydroxyurea to a 21 percent reduction in annual medical costs for young children with sickle cell anemia; savings expected to grow. (Dr. Winfred Wang)
The results of the Baby HUG study are music to the ears of Emmanuel and Pamela Madu and to other parents of young children with sickle cell anemia.
The Know Your Sickle Status program, spearheaded by St. Jude Children’s Research Hospital, works with community partners to educate families on trait status for genetic disorder
The multicenter Baby HUG trial led by St. Jude Children’s Research Hospital investigators shows hydroxyurea reduces the most common symptoms of sickle cell anemia in children, raising hopes the drug will ease complications and improve patient quality of life.
Through two studies--HUSOFT and BABY HUG--St. Jude is offering hope to babies with sickle cell disease.
Treating babies who have sickle cell anemia (SCA) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease.